• Changes coming to the U.S. and European Regulator Agencies 
  • Emerging partnerships between Payers/Health Systems and Industry 
  • The essential role patients play in de-risking pathway from innovation to adoption 
  • New approaches to clinical trials making them more efficient and affordable 
  • Expedited global reach with improved chances of successful coverage decisions
  • Impending changes in funding of health technologies

EXCITE International's unique approach engages industry, payers, health systems, expert end-users and patients across the full pathway from innovation to adoption bringing these technologies to market with greater certainty and at a lower cost. 

Purchase Your Ticket

Keynote Speakers & Panelists

In order of appearance in the program.

  • Dr. Les Levin

    Dr. Les Levin CEO and CSO, EXCITE International

  • Dr. Rick Kuntz

    Dr. Rick Kuntz Senior VP and Chief Scientific, Clinical and Regulatory Officer, Medtronic, Inc.

  • Trent Haywood

    Dr. Trent Haywood Chief Medical Officer, Blue Cross Blue Shield Association

  • Sir Andrew Dillan

    Sir Andrew Dillon Chief Executive, NICE

  • Joe Gatewood

    Joe Gatewood VP for Global Strategy and Development, AdvaMed

  • Jeff Shuren

    Jeff Shuren Director, Center for Devices and Radiological Health, FDA

  • Naomi Aronson

    Naomi Aronson Executive Director of Clinical Evaluation, Innovation, and Policy, Blue Cross and Blue Shield Association

  • Tamara Syrek Jensen

    Tamara Syrek Jensen Director, Coverage and Analysis Group, Center for Medicare and Medicaid Services

  • Jo Carol Hiatt

    Dr. Jo Carol Hiatt Chair, National Product Council, Kaiser Permanente

  • Maroeska Rovers

    Maroeska Rovers Professor of Evidence Based Surgery, Radboud University

  • Karel Moons

    Karel Moons Professor of Clinical Epidemiology, Julius Center, Utrecht University

  • Shahira Bhimani

    Shahira Bhimani Director, MaRS EXCITE

  • Nina Pinwill

    Nina Pinwill Head of Commercial Operations, National Health Service

  • Pall Johnsson

    Páll Jónsson Associate Director of Research and Development, NICE

  • Bryan Luce

    Bryan Luce CEO, LUCE Outcomes Research

  • Jeff Popma

    Dr. Jeff Popma Professor of Medicine, Harvard Medical School

  • Peter McCulloch

    Peter McCulloch Professor of Surgical Science and Practice, University of Oxford

  • Elise Berliner

    Elise Berliner Director of the Technology Assessment Program, AHRQ

  • Murray Sheldon

    Murray Sheldon Associate Director for Technology and Innovation Center for Devices and Radiological Health, FDA

  • Sean Tunis

    Dr. Sean Tunis President and CEO, Center for Medical Technology Policy

  • Mark Leahey

    Mark Leahey CEO, MDMA

  • Carl Gilhuus-Moe

    Carl Gilhuus-Moe Chair, Norway HealthTech

  • Brian Lewis

    Brian Lewis CEO, MEDEC

  • Per Olav Vandvik

    Per Olav Vandvik Professor, Department of Health Management and Health Economics, University of Oslo

Download Program

Purchase Your Ticket


Space is Limited. Register Now!

Download Program


March 26 - Open Sessions
March 27 - Closed Sessions


555 11th St NW »
Washington, DC U.S.A.


We strongly encourage you to book your accommodations as soon as possible.

Book Suggested Hotels

Our Sponsors

Platinum Sponsor


Host Sponsor

Medical Device Manufacturers Association

Canada's Medical Technology Companies

Purchase Your Ticket


A not-for-profit initiative, EXCITE International is a global collaboration of key stakeholders — innovators/industry, regulators, payers, health systems, patients, scientists and end-users — working together in the premarket space to change the paradigm of health technology innovation and adoption.

Our unique approach helps innovators of breakthrough technologies achieve accelerated adoption with greater certainty, at a lower cost. Faster market adoption improves patient outcomes and drives health system efficiencies.

Have a question? Please contact us at info@exciteinternational.com.

Get Tickets »